NTGN - Neon Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development60,42537,19519,673
Selling General and Administrative18,27610,8927,749
Non Recurring---
Total Operating Expenses78,70148,08727,422
Operating Income or Loss-78,701-48,087-27,422
Income from Continuing Operations
Total Other Income/Expenses Net1,767551-11
Earnings Before Interest and Taxes-78,701-48,087-27,422
Interest Expense---
Income Before Tax-76,934-47,536-27,433
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-76,934-47,536-27,433
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-76,934-47,536-27,433
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-83,305-57,932-30,422